In this episode, Professor Malcolm Hopwood speaks with Professor David Castle, from the University of Tasmania in Hobart, & Professor Christoph Correll, from the Department of Child and Adolescent Psychiatry – Chanté University, in Berlin, & Professor of Psychiatry at the Zucker School of Medicine in Hofstra/Northwell, New York.
Login to stream the interview below or access our private podcast. If you don't have a login, subscribe for free now!
Psychiatry
Psychiatry: Long-acting injectable antipsychotics (LAIs) play a crucial role in improving adherence and outcomes for patients with schizophrenia, but existing options often come with challenges like complex dosing schedules and the need for oral supplementation.
In this episode we discuss a newly available LAI that simplifies initiation and offers rapid therapeutic levels without the need for oral supplementation. Our experts explore its clinical advantages, practical applications, and real-world experiences, providing valuable insights for psychiatrists looking to enhance treatment strategies.
Tune in for expert perspectives on integrating this innovation into practice.
Ramsay Health Care Professor of Psychiatry, University of Melbourne.
Prof. of Psychiatry, University of Tasmania, Hobart.
Dept of Child and Adolescent Psychiatry Chanté University, Berlin Germany, & Professor of Psychiatry, the Zucker School of Medicine, Hofstra/Northwell, New York, USA.
Supported by: Produced by DrivetimeRadio with the support of Servier. Produced April 2025.
Tap the share icon 
and select 'Add to Home Screen' to add the site to your home screen for quick access!
Access private podcast